Secondary structure and disorder prediction |   |
  |   |
1 | . | . | . | . | . | . | . | . | 10 | . | . | . | . | . | . |
Sequence |   |
M | N | N | S | T | K | F | C | F | S | R | F | R | T | G | N |
Secondary structure |   |
|
| | | | | | | | | | | |
|
|
|
SS confidence |   |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Disorder |   |
? | ? | ? | ? | ? |
|
|
|
|
| ? | ? | ? | ? | ? | ? |
Disorder confidence |   |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
  |
Confidence Key |
High(9) |   |
  |
  |
  |
  |
  |
  |
  |
  |
  |
Low (0) |
? | Disordered |
| Alpha helix |
| Beta strand |
Hover over an aligned region to see model and summary info
Please note, only up to the top 20 hits are modelled to reduce computer load
|
1 |
|
PDB 3pp4 chain P
Region: 4 - 10 Aligned: 7 Modelled: 7 Confidence: 10.8% Identity: 57% PDB header:immune system Chain: P: PDB Molecule:b-lymphocyte antigen cd20;
PDBTitle: epitope characterization and crystal structure of ga101 provide2 insights into the molecular basis for the type i / type ii3 distinction of anti- cd20 antibodies
Phyre2
2 |
|
PDB 2osl chain Q
Region: 4 - 10 Aligned: 7 Modelled: 7 Confidence: 9.6% Identity: 57% PDB header:immune system Chain: Q: PDB Molecule:b-lymphocyte antigen cd20;
PDBTitle: crystal structure of rituximab fab in complex with an2 epitope peptide
Phyre2
|
Detailed template information |   |
Binding site prediction |   |
Due to computational demand, binding site predictions are not run for batch jobs
If you want to predict binding sites, please manually submit your model of choice to 3DLigandSite
Phyre is for academic use only
Please cite: Protein structure prediction on
the web: a case study using the Phyre server |
Kelley LA and Sternberg MJE. Nature Protocols
4, 363 - 371 (2009) [pdf] [Import into BibTeX] |
  |
If you use the binding site
predictions from 3DLigandSite, please also cite: |
3DLigandSite: predicting ligand-binding sites using similar structures. |
Wass MN, Kelley LA and Sternberg
MJ Nucleic Acids Research 38, W469-73 (2010) [PubMed] |
  |
|
|
|